Global Opioid Use Disorder Market Set for Rapid Growth, to reach Value around USD 7.65 Billion By 2032

20-Jun-2024 | Zion Market Research

Zion Market Research has published a new report titled “Opioid Use Disorder Market By Drug (Buprenorphine, Methadone and Naltrexone), and By Region – Global Industry Perspective Comprehensive Analysis and Forecast, 2024 - 2032”. According to the report, the global opioid use disorder market size was valued at approximately USD 3.10 billion in 2023 and is predicted to reach around USD 7.65 billion by the end of 2032, expanding at a CAGR of around 10.58% from 2024 to 2032.

Global Opioid Use Disorder Market Size

Browse the full “Opioid Use Disorder Market By Drug (Buprenorphine, Methadone and Naltrexone), and By Region – Global Industry Perspective Comprehensive Analysis and Forecast, 2024 - 2032” Report at https://www.zionmarketresearch.com/report/opioid-use-disorder-market

Opioids, which are medicinally used for pain relief, have debilitating effects on the analgesic and central nervous system as well as euphoria potential. Opioid use disorder (OUD) may include misuse of prescription opioid drugs, use of diverted opioid drugs, or use of heroin that is illegally obtained. Opioid use disorder is usually a chronic, recurring condition associated with levels of morbidity and mortality significantly higher.

The rising number of patients with opioid-related addiction, increased government efforts and increased support from NGOs and agensis are key factors driving the market for opioid use disorder care. The NGOs organize various programs and initiatives with the help of government organizations and many others to increase awareness of the clinical ill-effects of Opioid abuse. The aim of these programs is to eliminate illicit drug use in federal workplaces and lead to drug-free all workplaces. Nevertheless, the factors that limit the growth of this market are individuals ' inability to pursue treatment modalities and the discontinuation of behavioral treatments that contribute to relapse. Government initiatives and funding are important tools for this sector.

The market for Opioid Use Disorder is segmented based on drugs and region. Based on Drugs, the market is segmented into Buprenorphine, Methadone and Naltrexone. Buprenorphine is further classified into Bunavail, Sublocade, Suboxone, Zubsolv and Others. The major revenue generating segment in 2023 was buprenorphine. The most widely prescribed drugs for opioid use disorder include buprenorphine / naloxone sublingual tablet, branded suboxone and buprenorphine sublingual tablet. Because of its excellent clinical profile, Suboxone Film is the most prescribed drug on the opioid use disorder market. High effectiveness in addiction treatment, low potential for abuse & relatively slight adverse effects and favorable type exposure are factors that can be contributed to this drug's high acceptance.

Geographic segmentation includes the current and forecast demand for Asia Pacific, North America, Latin America, Europe, and Middle East & Africa with its further bifurcation into major countries. In 2023, North America was the largest revenue-generating market and is expected to show the same pattern over the forecast period. The opioid epidemic of the U.S. and Canada is one of the major contributing factors to the largest market share in North America. A variety of measures are being pursued by governments to tackle the crisis.

Some of the players included in Opioid Use Disorder market are Indivior, Alkermes, Titan Pharmaceuticals, Hikma Pharmaceuticals, Teva Pharmaceuticals, MediciNova, Orexo, Camurus, and Omeros amongst others.

The report segments global Opioid Use Disorder market as follows:

Global Opioid Use Disorder Market: Drug Segment Analysis

  • Buprenorphine
    • Bunavail
    • Sublocade
    • Suboxone
    • Zubsolv
    • Others
  • Methadone
  • Naltrexone

Global Opioid Use Disorder Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed